Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases
- PMID: 15184297
- DOI: 10.1161/01.CIR.0000128363.85581.E1
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases
Abstract
A group of relatively uncommon but important genetic cardiovascular diseases (GCVDs) are associated with increased risk for sudden cardiac death during exercise, including hypertrophic cardiomyopathy, long-QT syndrome, Marfan syndrome, and arrhythmogenic right ventricular cardiomyopathy. These conditions, characterized by diverse phenotypic expression and genetic substrates, account for a substantial proportion of unexpected and usually arrhythmia-based fatal events during adolescence and young adulthood. Guidelines are in place governing eligibility and disqualification criteria for competitive athletes with these GCVDs (eg, Bethesda Conference No. 26 and its update as Bethesda Conference No. 36 in 2005). However, similar systematic recommendations for the much larger population of patients with GCVD who are not trained athletes, but nevertheless wish to participate in any of a variety of recreational physical activities and sports, have not been available. The practicing clinician is frequently confronted with the dilemma of designing noncompetitive exercise programs for athletes with GCVD after disqualification from competition, as well as for those patients with such conditions who do not aspire to organized sports. Indeed, many asymptomatic (or mildly symptomatic) patients with GCVD desire a physically active lifestyle with participation in recreational and leisure-time activities to take advantage of the many documented benefits of exercise. However, to date, no reference document has been available for ascertaining which types of physical activity could be regarded as either prudent or inadvisable in these subgroups of patients. Therefore, given this clear and present need, this American Heart Association consensus document was constituted, based largely on the experience and insights of the expert panel, to offer recommendations governing recreational exercise for patients with known GCVDs.
Similar articles
-
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis.Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):876-85. doi: 10.1097/01.hjr.0000238393.96975.32. Eur J Cardiovasc Prev Rehabil. 2006. PMID: 17143118
-
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.Eur Heart J. 2005 Mar;26(5):516-24. doi: 10.1093/eurheartj/ehi108. Epub 2005 Feb 2. Eur Heart J. 2005. PMID: 15689345 Review.
-
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.J Am Coll Cardiol. 2008 Dec 9;52(24):1990-6. doi: 10.1016/j.jacc.2008.08.055. J Am Coll Cardiol. 2008. PMID: 19055990
-
Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities.Br J Sports Med. 2009 Sep;43(9):685-9. doi: 10.1136/bjsm.2008.054882. Br J Sports Med. 2009. PMID: 19734503 Review.
-
Making prudent recommendations for return-to-play in adult athletes with cardiac conditions.Curr Sports Med Rep. 2011 Mar-Apr;10(2):65-77. doi: 10.1249/JSR.0b013e3182159a55. Curr Sports Med Rep. 2011. PMID: 21623288 Review.
Cited by
-
Cardiomyopathy mutations in the tail of β-cardiac myosin modify the coiled-coil structure and affect integration into thick filaments in muscle sarcomeres in adult cardiomyocytes.J Biol Chem. 2013 Nov 1;288(44):31952-62. doi: 10.1074/jbc.M113.513291. Epub 2013 Sep 18. J Biol Chem. 2013. PMID: 24047955 Free PMC article.
-
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.Clin Res Cardiol. 2009 Mar;98(3):141-58. doi: 10.1007/s00392-009-0751-4. Epub 2009 Feb 9. Clin Res Cardiol. 2009. PMID: 19205777 Review.
-
Palpitations in athletes.Sports Med. 2008;38(8):687-702. doi: 10.2165/00007256-200838080-00006. Sports Med. 2008. PMID: 18620468
-
Sudden Cardiac Death in the Young.Circulation. 2016 Mar 8;133(10):1006-26. doi: 10.1161/CIRCULATIONAHA.115.020254. Circulation. 2016. PMID: 26951821 Free PMC article. Review.
-
Athletes with Implantable Cardioverter Defibrillators.Clin Sports Med. 2015 Jul;34(3):473-87. doi: 10.1016/j.csm.2015.03.010. Clin Sports Med. 2015. PMID: 26100423 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical